Showing results (141-150 of 710) with videos related to
Sort By:
Pageof 71
Expert Opinion on Investigational Drugs|February 28, 2020
The use of biologics in the treatment of autoimmune liver diseaseChristopher Chang, Atsushi Tanaka, Christopher Bowlus, et al.Clinics in Liver Disease|October 21, 2022
Immunologic Responses and the Pathophysiology of Primary Biliary CholangitisRuiling Chen, Ruqi Tang, Xiong Ma, et al.Clinics in Liver Disease|September 28, 2018
The Genetics and Epigenetics of Primary Biliary CholangitisAtsushi Tanaka, Patrick S C Leung, Merrill Eric GershwinCurrent Opinion in Immunology|July 17, 2025
HLA-B27 as a potential target for the cure of axial spondyloarthritisCarlo Cannistrà, Suraj Timilsina, Merrill Eric Gershwin, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2001
Impaired development of T lymphoid precursors from pluripotent hematopoietic stem cells in New Zealand Black miceYoshiko Hashimoto, Encarnacion Montecino-Rodriguez, M Eric Gershwin, et al.Autoimmunity Reviews|July 10, 2003
Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobioticsS Alice Long, Judy Van de Water, M Eric GershwinDisease Markers|February 8, 2011
Infectious agents and xenobiotics in the etiology of primary biliary cirrhosisCarlo Selmi, Maria De Santis, Francesca Cavaciocchi, et al.Genome Medicine|March 3, 2010
Genomic variants associated with primary biliary cirrhosisCarlo Selmi, Natalie J Torok, Andrea Affronti, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 5, 2002
Studies of sick building syndrome. IV. MycotoxicosisYehudith Assoulin-Daya, Albin Leong, Yehuda Shoenfeld, et al.International Archives of Allergy and Immunology|April 22, 2010
Macrophage activation syndrome in autoimmune diseaseSean Deane, Carlo Selmi, Suzanne S Teuber, et al.Pageof 71